[
    [
        {
            "time": "",
            "original_text": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
            "features": {
                "keywords": [
                    "医药行业",
                    "调整",
                    "均衡",
                    "内生成长",
                    "一二线公司"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]